Psychiatry is a branch of medicine, but it has always carried more cultural baggage than most other medical specialties. People rarely feel embarrassed about seeing a cardiologist or dermatologist. Mention an appointment with a psychiatrist, however, and fear, uncertainty, and old stereotypes can quickly appear.

Some people worry that seeing a psychiatrist means something must be seriously wrong with them. Others are afraid of psychiatric medication, believing that once they start taking it, they will become dependent on it or will need it forever. These fears are understandable, but many are based on myths rather than on how modern psychiatric care actually works in the United States.

A psychiatrist is an M.D. or D.O. who specializes in the diagnosis, treatment, and prevention of mental, emotional, and behavioral disorders. Psychiatric treatment can involve medication, psychotherapy, other medical treatments, or a combination depending on the person's needs. So it may be worth separating some of the most persistent myths from the facts.

Myth #1: If You See a Psychiatrist, You Must Have a Severe Mental Illness

This may be the most powerful misconception of all. For some people, simply scheduling a psychiatric appointment feels almost like admitting that they have a serious psychiatric disorder. But psychiatrists see people for many different reasons, including persistent anxiety, panic attacks, depression, mood changes, sleep problems, difficulty functioning, and symptoms that may have become difficult to manage without professional help. Serious psychiatric disorders certainly exist, but they represent only part of psychiatry.

The numbers help put this into perspective. NIMH estimates that 8.3% of U.S. adults experienced a major depressive episode in 2021. By comparison, estimates for schizophrenia and related psychotic disorders in the United States range from approximately 0.25% to 0.64%. Mental health concerns can also appear during specific periods of life. CDC data from 2018 found postpartum depressive symptoms in 13.2% of surveyed women with a recent live birth across participating sites.

Seeing a psychiatrist, therefore, should not automatically be interpreted as evidence of a severe illness. Sometimes it simply means that symptoms have begun interfering with sleep, work, relationships, concentration, or everyday life enough to deserve medical attention. Seeking psychiatric care is healthcare.

Myth #2: Psychiatric Medications Are Basically “Drugs” That Cause Addiction

The term psychotropic medication can sound frightening if someone has never encountered it outside psychiatry. But “psychotropic” is a broad term. Psychiatric medications include antidepressants, anti-anxiety medications, stimulants, antipsychotics, mood stabilizers, and other medicines used for specific mental health conditions.

It is also important not to swing too far in the opposite direction and claim that psychiatric medications can never cause dependence. Different medications have very different risk profiles. For example, antidepressants are not the same as benzodiazepines. Benzodiazepines can produce tolerance and physical dependence, particularly with continued use. The FDA requires prominent warnings about the risks of misuse, addiction, physical dependence, and withdrawal with this medication class.

This distinction matters because physical dependence, withdrawal symptoms, and addiction are not automatically the same thing.

Another common misunderstanding appears when someone feels better, stops medication earlier than recommended, and then notices that the original symptoms return. The person may conclude, “Now I can't function without this medication, so I must be addicted.” That conclusion is not necessarily correct. Sometimes the underlying condition has simply not been treated long enough. In other situations, stopping medication too quickly can itself produce discontinuation or withdrawal symptoms. NIMH recommends discussing medication changes with a healthcare provider rather than abruptly stopping prescribed treatment.

Myth #3: Taking Psychiatric Medication for a Long Time Means Something Has Gone Wrong

Another fear often appears when treatment lasts longer than expected. A patient may be comfortable taking medication for several weeks but become uneasy when a psychiatrist begins talking about months or longer. Yet duration alone does not tell us whether treatment is appropriate.

Medicine already accepts long-term treatment in many areas of healthcare. People may take medication for hypertension, epilepsy, diabetes, thyroid disease, or other chronic conditions for years. Psychiatric treatment can sometimes follow a similar principle. Some mental health conditions improve and medication can eventually be reduced or discontinued. Others may recur, requiring longer-term maintenance treatment.

The goal is not to keep someone on medication simply because treatment has started. The goal is to balance symptom control, side effects, functioning, relapse risk, and quality of life.

Certain psychiatric medications also require ongoing medical monitoring. For example, NIMH notes that people taking some antipsychotic medications may need monitoring of weight, glucose, and lipid levels, while lithium treatment generally involves monitoring lithium levels as well as kidney and thyroid function. In other words, long-term treatment should be an active medical decision, not an automatic one.

Myth #4: A Medication With a Long List of Side Effects Must Be Extremely Dangerous

Opening the medication information and seeing several pages of possible side effects can be alarming. It is easy to look at that list and think, “How can anyone safely take this?” But the number of effects listed does not tell you what will happen to you personally.

Some adverse effects are common and mild. Others are uncommon but important enough that patients need to know about them. Risks may also depend on age, dose, other medications, existing medical conditions, and the particular drug being prescribed. Psychiatric medications are no different from other medications in this respect.

The more useful questions are:

• How often does this side effect occur?
• How serious is it?
• What symptoms should I watch for?
• Are there medical conditions or other medications that change my risk?

Finding the medication that provides meaningful benefit with acceptable side effects sometimes requires adjustment. NIMH specifically notes that people respond differently to psychiatric medications and that finding the most effective treatment with the fewest side effects may take more than one attempt. A frightening-looking medication guide is therefore not, by itself, a reason to assume that a medication is inappropriate.

Myth #5: One Psychiatrist Appointment Should Be Enough

Psychiatric care is sometimes imagined as a single appointment: explain the symptoms, receive a prescription, and leave. In reality, treatment often requires follow-up.

A psychiatrist may need to know whether symptoms are improving, whether side effects have appeared, whether sleep or anxiety has changed, and whether the dose remains appropriate. Some medications also require laboratory or physical-health monitoring. Treatment plans can change as new information becomes available.

That does not mean psychiatric treatment must continue indefinitely for everyone. Some people need relatively short-term care. Others benefit from periodic follow-up over a longer period. What matters is that psychiatric treatment is usually a process rather than a single decision made during one appointment.

Psychiatry Without the Myths

Perhaps the hardest thing about psychiatric care is that people often arrive carrying not only their symptoms but also years of cultural assumptions about what psychiatry means. They may fear being labeled. They may worry about medication changing their personality. They may interpret long-term treatment as weakness or assume that returning symptoms automatically mean addiction.

Modern psychiatric care is more nuanced than those fears suggest.

A psychiatric appointment does not automatically mean severe mental illness. Psychiatric medications are not one single category with one level of risk. Some treatments are brief, others are longer-term, and medication decisions should be based on an individual's symptoms, health, response to treatment, side effects, and personal circumstances. Understanding these distinctions can make psychiatric care feel less mysterious—and allow decisions about mental health to be based more on medicine than on stigma.

References

• American Psychiatric Association. “What Is Psychiatry?” American Psychiatric Association.
  Explains the role of psychiatry in the United States, including that psychiatrists are M.D. or D.O. physicians and may use medication, psychotherapy, psychosocial interventions, and other treatments. Web resource; no fixed page numbers.
• National Institute of Mental Health. “Major Depression.” National Institutes of Health.
  Provides U.S. prevalence data for major depressive episodes, including the estimate that 8.3% of U.S. adults experienced a major depressive episode in 2021. Web statistical resource; no fixed page numbers.
• National Institute of Mental Health. “Schizophrenia.” National Institutes of Health.
  Summarizes U.S. epidemiological research and reports prevalence estimates of approximately 0.25%–0.64% for schizophrenia and related psychotic disorders. Web statistical resource; no fixed page numbers.
• Bauman BL, Ko JY, Cox S, et al. “Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression — United States, 2018.” Morbidity and Mortality Weekly Report. 2020;69(19):575–581.
  Reports CDC Pregnancy Risk Assessment Monitoring System findings, including postpartum depressive symptoms among 13.2% of respondents across participating U.S. sites. Pages 575–581.
• National Institute of Mental Health. “Mental Health Medications.” National Institutes of Health.
  Reviews major categories of psychiatric medications, expected effects, side effects, monitoring, medication changes, and the risks of abruptly stopping treatment. It also discusses tolerance and dependence associated with benzodiazepines. Web resource; no fixed page numbers.
• U.S. Food and Drug Administration. “Benzodiazepine Drug Class: Drug Safety Communication — Boxed Warning Updated to Improve Safe Use.” September 23, 2020.
  Confirms FDA warnings regarding abuse, misuse, addiction, physical dependence, and withdrawal reactions associated with benzodiazepines and recommends gradual tapering when discontinuation is appropriate. Web resource; no fixed page numbers.